Patents by Inventor Catherine J. Strietzel

Catherine J. Strietzel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BOVINE ANTIBODY VARIANTS
    Publication number: 20230416410
    Abstract: The invention relates generally to bovine antibody variants and uses thereof. Specifically, the invention relates to mutations in the constant region of bovine antibody for improving various characteristics.
    Type: Application
    Filed: November 19, 2021
    Publication date: December 28, 2023
    Inventors: Catherine J. Strietzel, Sandra Ann Marie Lightle, Henry Luis Campos, Yaqi Zhu, Gregory John Fici, Alexander Pogacsas Ruhland Bally, Prajna SHANBHOGUE
  • FELINE ANTIBODY VARIANTS FOR IMPROVING STABILITY
    Publication number: 20230250155
    Abstract: The invention relates generally to feline antibody variants and uses thereof. Specifically, the invention relates to mutations in the constant region of feline antibody for improving its stability.
    Type: Application
    Filed: June 24, 2021
    Publication date: August 10, 2023
    Inventors: John G. Hoogerheide, Catherine J. Strietzel, Sandra Ann Marie Lightle, Veronica T. Mutchler
  • ANTI-TGFB ANTIBODIES AND THERAPEUTIC USES THEREOF
    Publication number: 20220119513
    Abstract: The present disclosure encompasses novel anti-TGF? antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of TGF?-related disorders, particularly in for the management of fibrosis related disorders in canines and felines.
    Type: Application
    Filed: June 7, 2021
    Publication date: April 21, 2022
    Inventors: Lisa Marie BERGERON, Gary F. Bammert, Henry Luis Campos, Sandra Ann Marie Lightle, Catherine J. Strietzel
  • ANTI-NGF ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20220106391
    Abstract: The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same. The disclosure further provides use of the novel antibodies, antigen binding proteins and/or nucleotide of the invention for the treatment and/or prevention of NGF related disorders, particularly in for the management of pain.
    Type: Application
    Filed: October 7, 2021
    Publication date: April 7, 2022
    Inventors: Lisa Marie Bergeron, Catherine J. Strietzel, Gary F. Bammert, Graeme Bainbridge